Potential cost-effectiveness of aspirin (ASA) chemoprevention against esophageal adenocarcinoma (EAC) and colorectal cancer (CRC) in patients with Barrett's esophagus (BE)
Keyword(s):
2019 ◽
Vol 24
(1)
◽
pp. 8-18
◽
Keyword(s):
Keyword(s):
Keyword(s):